Caitlin John’s Insmed INSM Stock Holding History

Caitlin John’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.07K	Hold	10	–	–	﹤0.01%	858
2026 Q1	$1.64K	Buy	+10	New	+$1.54K	﹤0.01%	737

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Caitlin John's INSM Position: Q2 2026 in Review

Caitlin John held its Insmed (INSM) position steady in Q2 2026 at 10 shares worth $1.07K. The position accounts for ﹤0.01% of the portfolio, ranked #858.

Caitlin John first reported a position in INSM in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.64K in Q1 2026. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Caitlin John held 10 shares of Insmed worth $1.07K as of Q2 2026.
Caitlin John left its Insmed share count unchanged in Q2 2026.
Insmed made up ﹤0.01% of Caitlin John's portfolio in Q2 2026, its #858 holding.
Caitlin John first reported a position in Insmed in Q1 2026 and has held it in 2 quarters since.
Caitlin John's Insmed position peaked at $1.64K in Q1 2026.
665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Caitlin John's 13F filing for Q2 2026, filed 17 Aug 2026.